CA
GSK icon

Commerzbank Aktiengesellschaft’s GSK GSK Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-97,102
Closed -$5.18M – 756
2019
Q3 		$5.18M Hold
97,102
– – 0.04% 280
2019
Q2 		$4.86M Sell
97,102
-1,185
-1% -$59.5K 0.04% 301
2019
Q1 		$5.13M Sell
98,287
-6,152
-6% -$307K 0.05% 260
2018
Q4 		$4.99M Sell
104,439
-10,368
-9% -$511K 0.05% 263
2018
Q3 		$5.76M Buy
114,807
+8,328
+8% +$423K 0.05% 258
2018
Q2 		$5.37M Sell
106,479
-9,832
-8% -$495K 0.05% 267
2018
Q1 		$5.68M Sell
116,311
-18,366
-14% -$855K 0.06% 245
2017
Q4 		$5.97M Buy
134,677
+117,568
+687% +$5.43M 0.07% 235
2017
Q3 		$868K Buy
17,109
+6,515
+61% +$331K 0.01% 494
2017
Q2 		$571K Sell
10,594
-1,758
-14% -$93.7K 0.01% 498
2017
Q1 		$651K Buy
12,352
+3,288
+36% +$167K 0.01% 573
2016
Q4 		$436K Buy
9,064
+1,856
+26% +$91.7K 0.01% 649
2016
Q3 		$389K Buy
7,208
+947
+15% +$51.9K 0.01% 641
2016
Q2 		$339 Hold
6,261
– – ﹤0.01% 794
2016
Q1 		$317K Sell
6,261
-96,709
-94% -$4.82M ﹤0.01% 853
2015
Q4 		$5.19M Buy
102,970
+2,563
+3% +$131K 0.04% 297
2015
Q3 		$4.83M Buy
100,407
+37,030
+58% +$1.93M 0.04% 284
2015
Q2 		$3.3M Buy
63,377
+48,613
+329% +$2.74M 0.02% 459
2015
Q1 		$852K Buy
14,764
+7,124
+93% +$408K 0.01% 832
2014
Q4 		$408K Buy
7,640
+377
+5% +$21.1K ﹤0.01% 1040
2014
Q3 		$417K Buy
7,263
+1,120
+18% +$68.7K ﹤0.01% 995
2014
Q2 		$411K Sell
6,143
-759
-11% -$51.4K ﹤0.01% 1033
2014
Q1 		$461K Sell
6,902
-447
-6% -$30.2K ﹤0.01% 990
2013
Q4 		$473K Sell
7,349
-2,154
-23% -$140K ﹤0.01% 1067
2013
Q3 		$596K Buy
9,503
+2,437
+34% +$157K ﹤0.01% 939
2013
Q2 		$441K Buy
+7,066
New +$448K ﹤0.01% 1105

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Commerzbank Aktiengesellschaft's GSK Position: Q4 2019 in Review

Commerzbank Aktiengesellschaft sold out of GSK (GSK) in Q4 2019, closing a stake of 97,102 shares — an estimated $5.18M sold.

Commerzbank Aktiengesellschaft first reported a position in GSK in Q2 2013 and held it in 26 quarters. The position peaked at $5.97M in Q4 2017. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

  • Commerzbank Aktiengesellschaft reported no remaining GSK position as of Q4 2019 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 97,102 GSK shares in Q4 2019, an estimated $5.18M.
  • Commerzbank Aktiengesellschaft first reported a position in GSK in Q2 2013 and held it in 26 quarters.
  • Commerzbank Aktiengesellschaft's GSK position peaked at $5.97M in Q4 2017.
  • 894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2019, filed 17 Jan 2020.